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Summary
Background.— The minute ventilation/carbon dioxide production (VE/VCO2) slope and peak
circulatory power, like peak oxygen consumption (VO2), possess strong prognostic values in
heart failure but have not been studied after ventricular resynchronization.
Aims.— In this retrospective study, we evaluated the evolution of ventilatory response, effort
capacity, functional status, peak circulatory power and echocardiographic variables, 6 months
after cardiac resynchronization therapy (CRT).
Methods.— Thirty subjects (mean age, 60± 12 years) underwent symptom-limited exercise
testing (CPX) with ventilatory expired gas analysis before and 6 months after CRT. The VE/VCO2
slope was measured from rest to the end of exercise. Echocardiography was performed in stable
clinical and pharmacological conditions.
Results.— Mean New York Heart Association (NYHA) status improved signiﬁcantly from 2.9 to
1.8 (p < 0.001). Signiﬁcant improvements were seen in exercise tolerance (evaluated by peak
VO ; from 13.1± 3.1 to 15.3± 5.6mL/kg/min, p = 0.02), VE/VCO slope (from 44.4± 19.2 to2 2
39.6± 13.8, p = 0.003) and maximal workload (from 74± 24 to 82± 26W, p = 0.02). Mean peak
circulatory power improved from 1663± 494 to 2125± 1014mmHgmL/kg/min (p = 0.009). Mean
left ventricular ejection fraction increased from 25% to 29% (p = 0.01). Mean end-systolic and
end-diastolic left ventricular volumes decreased signiﬁcantly from 155 to 128mL and from 203
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dynamique. Nos résultats soulignent l’importance de l’étude de la réponse ventilatoire et de
la puissance circulatoire comme marqueurs fonctionnels de réponse après resynchronisation
biventriculaire.
© 2010 Elsevier Masson SAS. Tous droits réservés.
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bpm beats per minute
CP circulatory power
CPX symptom-limited exercise testing
CRT cardiac resynchronization therapy
LVEF left ventricular ejection fraction
NYHA New York Heart Association
VCO2 carbon dioxide production
VE minute ventilation
VO2 oxygen consumption
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RT is one of the major treatments for patients with chronic
eart failure. Current recommended deﬁnitions are QRS
uration more than 120ms, LVEF less than 35%, NYHA symp-
om class III/IV and an optimal heart failure medical regimenculatory power 185
to 179mL, respectively (p < 0.05). Mean mitral regurgitation grade improved from 1.4± 1.0 to
1.1± 0.9 (p = 0.1). No strong correlation was found between echocardiographic changes and
improvement in ventilatory efﬁciency (VE/VCO2 slope; all r = 0.15—0.24). Patients with narrow
QRS complexes (< 130ms) did not show signiﬁcant improvement in functional or echocardio-
graphic variables other than NYHA status.
Conclusion.— Cardiac resynchronization therapy improved ventilatory and haemodynamic
responses. Our results highlight the potential value of new functional variables such as ven-
tilatory response and peak circulatory power as better markers for identifying responders to
CRT.
© 2010 Elsevier Masson SAS. All rights reserved.
Résumé
Background.— L’étude de la réponse ventilatoire par la pente de régression linéaire de la
ventilation minute et de la production de dioxyde de carbone (VE/VCO2) et la mesure de la
puissance circulatoire au cours d’une épreuve d’effort possède une valeur pronostique signiﬁ-
cative chez l’insufﬁsant cardiaque. L’évolution de la réponse ventilatoire n’a pas été étudiée
après resynchronisation biventriculaire.
Objectif.— L’objectif principal était d’étudier l’évolution de la réponse ventilatoire, de la
puissance circulatoire au pic et des paramètres échocardiographiques après resynchronisation
biventriculaire.
Méthodes et résultats.— Trente patients (âge moyen : 60± 12 ans) ayant bénéﬁcié d’une
épreuve d’effort avec mesure des échanges gazeux ainsi que d’une échocardiographie transtho-
racique avant et six mois après implantation ont été inclus. La réponse ventilatoire était
évaluée par la pente de régression linéaire de VE/VCO2 en incluant l’ensemble des points
du début à la ﬁn de l’exercice. Une valeur ponctuelle de VE/VCO2 était mesurée au pic
de l’exercice. La classe New York Heart Association (NYHA) était améliorée de 2,9 à 1,8
(p < 0,001). Le pic de VO2, la pente de régression de VE/VCO2 et la charge maximale au pic de
l’exercice étaient signiﬁcativement améliorés après resynchronisation, de 13± 3 à 15± 5mL/kg
par minute, de 44± 19 à 39± 13 (p = 0,02) et de 74± 24 à 82± 26W (p = 0,02) respective-
ment. La puissance circulatoire était augmentée de 1663± 494 à 2125± 1014mmHgml/kg par
minute (p = 0,009). La fraction d’éjection ventriculaire gauche s’est améliorée de 25% à 29%
(p = 0,01), ainsi que le volume télésystolique (155 à 128mL ; p = 0,002) et télédiastolique (203 à
179mL ; p = 0,004). L‘insufﬁsance mitrale était néanmoins améliorée de manière non signiﬁca-
tive (1,4± 1 à 1,1± 0,9 ; p = 0,1). Néanmoins, il n’a pas été retrouvé de corrélation signiﬁcative
entre l’amélioration de la réponse ventilatoire et celle des volumes ventriculaires gauches après
resynchronisation (valeur de r entre 0,15 et 0,24). Enﬁn, les patients présentant des QRS ﬁns
(< 130ms) ne présentaient aucune amélioration fonctionnelle objective ni échocardiographique
à l’exception de la classe NYHA.
Conclusion.— La resynchronisation biventriculaire améliore la réponse ventilatoire et hémo-1]. Previous major trials have conﬁrmed that CRT improves
unctional status (symptoms and NYHA symptom class),
ecreases acute heart failure hospitalizations [2] and global
ortality [3] and reverses left ventricular remodelling vari-
bles [4,5].
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Peak VO2 is one of the most important independent pre-
ictors of mortality and hospitalization for patients with
eart failure [6—8]. This functional variable represents func-
ional effort capacity and is improved signiﬁcantly by CRT
4,9], but is inﬂuenced by non-cardiac factors (age, moti-
ation, anaemia and obesity). Moreover, the clinical value
f the relationship between the VE and VCO2 relation-
hip, usually expressed as the VE/VCO2 slope, has been
roved in heart failure patients, in whom it has been
hown to be a signiﬁcant predictor of mortality and hos-
italization [10]. The VE/VCO2 slope seems to be a better
redictor of outcome than peak VO2 with regard to sub-
aximal effort [11] and subjective functional evaluation
6-minute walking test and quality of life score). In addition,
non-invasive haemodynamic measure of cardiac power
as assessed (by the measurement of peak ‘‘CP’’ during
PX using the product of both peak VO2 and systolic blood
ressure) as a strong prognostic predictor in heart fail-
re patients [12]. However, no study has been designed to
nvestigate ventilatory and haemodynamic responses after
RT.
Our aim was to evaluate peak VO2, VE/VCO2 slope,
YHA class symptom, peak CP, peak workload, left ven-
ricular volumes and LVEF, before and 6 months after CRT
mplantation, to study the ventilatory and haemodynamic
esponse evolution and to assess improvement in functional
nd echocardiographic variables. We aimed to conﬁrm the
ajor place of the ventilatory and haemodynamic responses
n the functional evaluation of heart failure patients after
RT.
aterials and methods
nclusion criteria
efractory heart failure patients matching the following
riteria were included in the study: indication for CRT
mplantation according to current guidelines (QRS duration
ore than 120ms, LVEF less than 35%, NYHA symptom class
II/IV and optimal heart failure medical regimen); complete
chocardiographic evaluation, including left ventricular vol-
me measurements; and cardiopulmonary exercise test
efore and 6 months after CRT.
chocardiographic measurement
chocardiograms were loaded onto a computer system
Echopac, GE) and all measurements were obtained for
ll patients at baseline and 6 months after implantation.
chocardiograms were analysed by a single experi-
nced sonographer. Sample loops were analysed off-line
n an Echopac computer workstation to obtain end-
iastolic and end-systolic left ventricular volumes using
he method of discs. LVEF was calculated as follows:
end-diastolic volume− end-systolic volume)/end-diastolic
olume× 100%. Mitral regurgitation was evaluated accord-
ng to the European Society of Echocardiography. A
econd blinded evaluation was performed for 10 echocar-
iograms by a second sonographer. Absolute values for
VEF interobserver variability were found to be less than
%.
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esting procedure and data collection
symptom-limited exercise test with ventilatory expired
as analysis using a cycle ergometer with a 10W/min pro-
ocol was performed in all patients (Medisoft). Continuous
lectrocardiogram measurements, manual blood pressure
easurements and heart rate recordings were monitored
t every stage. Data for VO2, VCO2, VE and workload were
ollected continuously throughout the exercise. Oxygen and
arbon dioxide sensors were calibrated using gases with
nown oxygen, nitrogen and carbon dioxide concentrations
efore each test.
Ventilatory efﬁciency on exercise was obtained from the
inear regression slope relating VE to VCO2 from the begin-
ing to peak exercise. Punctual VE/VCO2 ratio at the end of
xercise was also measured.
Peak CP was measured as the product of peak VO2 and
ystolic blood pressure, as described by Cohen-Solal et al.
12].
ubgroup analysis
esponders and non-responders to CRT were character-
zed. The responder subgroup was deﬁned as having
n end-systolic left ventricular volume reduction more
han 15% after CRT [5]. In addition, characteristics of
he patients with narrow QRS complexes (< 130ms) were
tudied, included remodelling variables, mitral regurgita-
ion grade, ventilatory response, peak CP, NYHA status
nd effort capacity by both peak VO2 and maximal
orkload.
tatistical analysis
aired t tests were used to compare differences between
ariables after CRT. All statistical tests with a p-value less
han 0.05 were considered to be signiﬁcant.
A Pearson r test was used to evaluate correlations
etween variables after CRT. All statistical tests with an
-value of more than 0.85 were considered to be highly
orrelated.
esults
atients
he baseline characteristics of included patients are summa-
ized in Table 1. Heart failure aetiology was ischaemic in 45%
nd non-ischaemic in 55% of patients. Patients had severely
epressed left ventricular function, with a mean LVEF of
5± 7%. Mean systolic blood pressure was 108± 18mmHg
t rest and 131± 21mmHg at peak exercise. Mean heart
ate was 81± 19 bpm at rest and 115± 23 bpm at peak
xercise. The mean peak VO2 value was 13± 3mL/kg/min.
he mean VE/VCO2 slope and the VE/VCO2 ratio at peak
xercise were 44± 19 and 48± 9 respectively. Mean max-
mal workload at peak exercise and mean peak CP were
4± 23W and 1663± 494mmHgmL/kg/min, respectively.
ean left ventricular end-diastolic and end-systolic volumes
ere 203± 76mL and 155± 65mL, respectively. Mean mitral
egurgitation grade was 1.45± 1.0. Most patients (93%) were
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Table 1 Characteristics of patients at baseline and after 6-month follow-up.
Baseline 6-month follow-up p-value
Total patients 30 (100) — —
Men 23 (77) — —
Women 7 (23) — —
Age (years) 60± 12 — —
Left ventricular ejection fraction (%) 25± 7 29± 7 0.01
Aetiology
Ischaemic 13 (45) — —
Non-ischaemic 17 (55) — —
Systolic blood pressure at rest (mmHg) 108± 18 107± 17 0.6
Systolic blood pressure at peak (mmHg) 131± 21 133± 26 0.6
Heart rate at rest (bpm) 81± 19 73± 11 0.05
Heart rate at peak (bpm) 115± 23 112± 27 0.5
Peak VO2 (mL/kg/min) 13± 3 15± 5 0.02
VE/VCO2 slope 44± 19 39± 13 0.003
VE/VCO2 ratio at peak exercise 48± 9 42± 7 < 0.001
Peak CP (mmHgmL/kg/min) 1663± 494 2125± 1014 0.009
Maximal workload (W) 74± 24 82± 26 0.02
 NYHA: 0 — 4 (13.3) —
 NYHA: 1 — 22 (73,4) —
 NYHA: 2 — 4 (13,3) —
 NYHA: 3 — 0 (0) —
Left ventricular end-systolic volume (mL) 155± 65 128± 55 0.002
Left ventricular end-diastolic volume (mL) 203± 76 179± 70 0.004
Mitral regurgitation (grade) 1.45± 1.0 1.12± 0.9 0.1
QRS duration (ms) 153± 38 — —
Beta-blocker 28 (93) — —
Diuretic 25 (83) — —
Conversion enzyme inhibitor 27 (89) — —
Data are mean± standard deviation or number (%).
 NYHA: difference between NYHA symptom class before and after cardiac resynchronization therapy.
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Cin NYHA symptom class II—III and 7% were in NYHA symptom
class IV. Mean QRS duration was 153± 38ms.
Six-month follow-up after cardiac
resynchronization therapy
At 6 months, values for mean peak VO2, the VE/VCO2
slope and the VE/VCO2 ratio at peak exercise were
15± 5mL/kg/min (p = 0.02), 39± 13 (p = 0.003) and 42± 7
(p = 0.00001), respectively. Mean systolic blood pressure was
107± 17mmHg at rest (p = 0.6) and 133± 26mmHg at peak
exercise (p = 0.6). Mean heart rate was 73± 11 bpm at rest
(p = 0.05) and 112± 27 bpm at peak exercise (p = 0.5). Mean
maximal workload at peak exercise and mean peak CP
were 82± 26W (p = 0.02) and 2125± 1014mmHgmL/kg/min
(p = 0.009), respectively. Left ventricular remodelling vari-
ables were improved signiﬁcantly. Mean left ventricular
end-diastolic and end-systolic volumes were 179± 70mL
(p = 0.004) and 128± 19mL (p = 0.002), respectively; mean
LVEF was 29± 8% (p = 0.01). Mean mitral regurgitation grade
improved to 1.12± 0.9 (p = 0.1). Twenty-seven patients
(90%) were in NYHA symptom class II and three (10%)
were in NYHA symptom class I (p < 0.0001). Mean NYHA
6
m
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t
btatus improved from 2.9 to 1.8 (p < 0.001). Four patients
ad no reduction in NYHA class; 22 patients had a
ne-class reduction and four patients had a two-class
eduction.
ubgroup analysis
eventeen patients (56.3%, 13 men, 62± 9 years) were
ncluded in the non-responder subgroup (Table 2). Major
eart failure aetiology was ischaemic in 53% and mean QRS
uration was 130± 10ms. After CRT, no signiﬁcant improve-
ent was found in functional or echocardiographic variables
including LVEF, end-systolic volume and mitral regurgita-
ion grade). Mean values for systolic blood pressure, and
eart rate at rest and at peak exercise were not improved
igniﬁcantly after CRT. Mean values for peak VO2 and the
E/VCO2 slope were 13± 2mL/kg/min and 43± 1 before
RT, and 14± 5mL/kg/min (p = 0.14) and 41± 8 (p = 0.57)
months after CRT, respectively. In addition, mean maxi-
al workload at peak exercise and mean peak CP improved
rom 77± 24 to 83± 25W (p = 0.8) and from 1741± 495
o 2055± 844mmHgmL/kg/min (p = 0.07), respectively. At
aseline, 16 (94%) non-responders were in NYHA symptom
188 J. Jaussaud et al.
Table 2 Characteristics of non-responder patients at baseline and after 6-month follow-up.
Baseline 6-month follow-up p-value
Total non-responder patients 17 (100) — —
Men 13 (77) — —
Women 4 (23) — —
Age (years) 62± 9 — —
Left ventricular ejection fraction (%) 29± 7 30± 8 0.4
Aetiology
Ischaemic 9 (53) — —
Non-ischaemic 8 (47) — —
Systolic blood pressure at rest (mmHg) 107± 19 105± 15 0.4
Systolic blood pressure at peak (mmHg) 132± 25 133± 27 0.9
Heart rate at rest (bpm) 77± 16 73± 9 0.3
Heart rate at peak (bpm) 111± 19 107± 20 0.4
Peak VO2 (mL/kg/min) 13± 2 14± 5 0.14
VE/VCO2 slope 43± 1 41± 8 0.57
VE/VCO2 ratio at peak exercise 44± 11 42± 9 0.07
Peak circulatory power (mmHgmL/kg/min) 1741± 495 2055± 844 0.07
Maximal workload (W) 77± 24 83± 25 0.8
NYHA: 0 — 4 (23.5) —
NYHA: 1 — 11 (64.7) —
NYHA: 2 — 2 (11.8) —
NYHA: 3 — 0 (0) —
NYHA status 2.8± 0.5 1.9± 0.25 0.01
Left ventricular end-systolic volume (mL) 130± 40 147± 45 0.2
Mitral regurgitation (grade) 1.05± 0.9 0.9± 0.9 0.2
QRS duration (ms) 130± 10 — —
Data are mean± standard deviation or number (%).
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h NYHA: difference between NYHA symptom class before and aft
lass II—III and one (6%) was in NYHA symptom class IV. After
RT, 16 (94%) non-responders were in NYHA symptom class
I—III and one (6%) was in NYHA symptom class I (p = 0.01).
our patients had no reduction in NYHA class; 11 patients
ad a one-class reduction and two patients had a two-class
eduction.
Thirteen patients (43.7%, 10 men, 61± 15 years) were
ncluded in the responder subgroup (Table 3). QRS duration
t baseline was 167± 34ms and an ischaemic cause was
ound in 31%. Mean values for systolic blood pressure and
eart rate at rest and at peak exercise were not improved
igniﬁcantly after CRT. Signiﬁcant improvement was found
n the ventilatory response, with a VE/VCO2 slope of 42± 5
efore CRT and 35± 5 (p = 0.003) after implantation. Mean
aximal workload at peak exercise and peak CP improved
rom 70± 22W to 84± 27W (p = 0.03) and from 1553± 474
o 2210± 1207mmHgmL/kg/min (p = 0.04), respectively. In
ddition, mean peak VO2 was 12± 3mL/kg/min before CRT
nd 14± 5mL/kg/min after CRT (p = 0.01). Mean LVEF and
nd-systolic volume values were 24± 8% and 154± 81mL
efore CRT, and 31± 7% (p = 0.009) and 81± 60mL (p = 0.01)
fter CRT, respectively. Mean mitral regurgitation grade
ecreased from 1.9± 1.0 to 1.4± 0.8 (p = 0.02). At baseline,
2 responders (93%) were in NYHA symptom class II—III and
ne (7%) was in NYHA symptom class IV. After CRT, 10 respon-
ers (77%) were in NYHA symptom class II and three (23%)
ere in NYHA symptom class I; 10 patients had a one-class
eduction and three patients had a two-class reduction.
a
p
0
i
(rdiac resynchronization therapy.
orrelations
o correlation was found between peak VO2 and VE/VCO2
lope improvement (r =−0.15), VE/VCO2 slope and LVEF
mprovement (r = 0.24) or VE/VCO2 slope and left ventricular
nd-systolic volume improvement (r = 0.24).
haracteristics of patients with narrow QRS
omplexes (< 130ms)
n this population (10 patients, 33.3%), no signiﬁ-
ant improvement was found in LVEF (from 29± 3% to
8± 5%, p = 0.45), end-systolic volume (from 141± 52 to
45± 43mL), peak VO2 (from 14± 3 to 16± 6mL/kg/min,
= 0.54), VE/VCO2 slope (from 53± 28 to 45± 20, p = 0.11),
aximal workload (from 83± 26 to 80± 27W, p = 0.87),
eak CP (from 1670± 478 to 1933± 726mmHgmL/kg/min,
= 0.13), mean systolic blood pressure at rest and at
eak exercise (from 103± 14 to 102± 13mmHg and from
31± 19 to 129± 22mmHg, respectively, both p = 0.6), mean
eart rate at rest (from 83± 18 to 74± 11 bpm, p = 0.07)
nd at peak exercise (from 117± 23 to 108± 22 bpm,
= 0.1) and mitral regurgitation (from grade 1.0± 0.8 to
.7± 0.9, p = 0.22). Nevertheless, a signiﬁcant improvement
n mean NYHA status was found, from 2.8± 0.6 to 1.9± 0.3
p = 0.004).
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Table 3 Characteristics of responder patients at baseline and after 6-month follow-up.
Baseline 6-month follow-up p-value
Total responder patients 13 (100) — —
Men 10 (77) — —
Women 3 (23) — —
Age (years) 61± 15 — —
Left ventricular ejection fraction (%) 24± 8 31.7± 7 0.009
Aetiology
Ischaemic 4 (31) — —
Non-ischaemic 9 (69) — —
Systolic blood pressure at rest (mmHg) 109± 18 109± 19 0.9
Systolic blood pressure at peak (mmHg) 128± 15 134± 27 0.5
Heart rate at rest (bpm) 85± 21 72± 14 0.07
Heart rate at peak (bpm) 120± 28 118± 31 0.7
Peak VO2 (mL/kg/min) 12± 3 14± 5 0.01
VE/VCO2 slope 42± 5 35± 5 0.003
VE/VCO2 ratio at peak exercise 47± 6 39± 8 0.002
Peak circulatory power (mmHgmL/kg/min) 1553± 474 2210± 1207 0.04
Maximal workload (W) 70± 22 84± 27 0.03
 NYHA: 0 — 0 (0) —
 NYHA: 1 — 10 (77) —
 NYHA: 2 — 3 (23) —
 NYHA: 3 — 0 (0) —
NYHA status 3.0± 0.4 1.8± 0.4 <0.001
Left ventricular end-systolic volume (mL) 154± 81 81± 62 0.01
Mitral regurgitation (grade) 1.9± 1.0 1.4± 0.8 0.02
QRS duration (ms) 167± 34 — —
Data are mean± standard deviation or number (%).
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Discussion
The main ﬁnding of this study was the signiﬁcant improve-
ment in ventilatory response after CRT in a refractory heart
failure population. In addition, functional variables and left
ventricular remodelling variables improved consistently 6
months after CRT, as shown in previous large studies [4,5].
Although no signiﬁcant improvement in ventilatory response
or other functional and echocardiographic variables was
found in the non-responder subgroup or in patients with
narrow QRS complexes (< 130ms), it is interesting to con-
sider that a signiﬁcant improvement in NYHA class was seen
in patients with narrow QRS complexes, which was found
independent of ventilatory response, maximal workload and
peak VO2, as shown in the RETHINQ trial [13]. Our results
highlight the potential interest of new functional variable
— ventilatory response— as a better marker for identify-
ing responders to CRT, including patients with narrow QRS
complexes (< 130ms).
Heart failure patients have constant, exaggerated hyper-
ventilation during exercise, leading to a decrease in effort
capacity and early fatigability. The ventilatory response
is evaluated by the VE/VCO2 regression slope during a
symptom-limited exercise test with ventilatory expired gas
analysis. An enhanced ventilatory response to exercise,
evaluated by a high VE/VCO2 slope value, has been shown to
be an independent prognostic marker of mortality and hos-
pitalization for patients with chronic heart failure [14,15].
p
c
c
t
ardiac resynchronization therapy.
n those studies, a VE/VCO2 regression slope value more than
5 was associated with a 1-year mortality rate of 30%. Evi-
ence has even suggested that the prognostic value of the
E/VCO2 slope could be greater than peak VO2, particu-
arly for patients undergoing sub-maximal effort, patients
reated with beta-blockers and those with LVEF less than
5% [14—17]. In fact, the main limitation is the frequent
ub-maximal effort during CPX, with an underestimation of
aximal peak VO2 leading to the wrong prognostic interpre-
ation.
Physiological determinants of enhanced ventilatory
esponse during effort in heart failure patients are not
et clear. An important cause of hyperpnoea during
ffort is the enlargement of physiological dead-space
nd ventilation-perfusion mismatch by alveolar hypoper-
usion from haemodynamic dysfunction [18,19]. Another
eterminant is early cardiorespiratory reﬂex dysregulation
17,18]. This is evidenced by increased peripheral and cen-
ral chemosensitivity, impaired sympathovagal balance with
ympathetic predominance, depressed baroreﬂex circula-
ion control and a higher level of activity in peripheral
uscle ergoreceptors [20,21].
In this study, peak CP was also studied. This sim-le haemodynamic non-invasive variable was described as
losely approaching ‘‘cardiac power’’ (production of both
ardiac output and main blood pressure) for the evalua-
ion of cardiac pumping function. Peak CP was measured
s the product of peak VO2 and systolic blood pressure at
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eak exercise, as described previously [12]. Peak CP was
onﬁrmed as a strong prognostic marker in heart failure
atients; it incorporates arterial-venous difference, heart
ate, stroke volume and blood pressure responses at peak
xercise. A signiﬁcant improvement in this variable was
btained in our study and a signiﬁcant increase was found
n responder patients but not in non-responder patients.
his study is the ﬁrst to investigate this variable after CRT,
ssessing improvement in haemodynamic capability after
RT and allowing differentiation between responders and
on-responders.
To the best of our knowledge, no previous study has
emonstrated the impact of CRT on ventilatory response.
e conﬁrmed that ventilatory response is improved by CRT.
oreover, in our investigation, we found no correlation
etween ventilatory response improvement and remod-
lling variable improvement after CRT. We can hypothesize
hat ventilatory response is improved 6 months after CRT
mplantation, independent of improvement in left ventricu-
ar remodelling variables. Cardiac capability after CRT could
robably lead to better ventilation/perfusion ratio at effort,
reduction in physiological dead-space during effort and
etter cardio-respiratory reﬂex regulation, as a result of
n improvement in effort capacity. However, this study was
ot designed to investigate the mechanisms of ventilatory
esponse improvement in patients with chronic heart failure
fter CRT.
The main study that tested CRT in narrow QRS (< 130ms)
eart failure patients (NYHA> 3, LVEF < 35%) was the
ETHINQ study, published in 2007 [13]. After a mean follow-
p of 6 months, no signiﬁcant improvement was seen in
eak VO2, 6-minute walking test, quality of life score and
tandard echocardiographic variables.
We conﬁrmed the data from the RETHINQ trial with
egard to the primary endpoint (peak VO2) and the secondary
ndpoints. In a population with narrow QRS complexes,
o signiﬁcant improvement in functional and echocar-
iographic variables was seen. In addition, signiﬁcant
mprovements in ventilatory response and peak CP were not
een after CRT. However, a signiﬁcant improvement in NYHA
tatus was conﬁrmed. In the RETHINQ study, NYHA status
as improved (p = 0.006) but the quality of life score and the
-minute walking test were not. This subjective functional
valuation appears to have a lack of sensitivity concerning
he response to CRT. In our investigation, a 6-minute walk-
ng test was not performed in all patients; but in previous
tudies, VE/VCO2 improvement correlated clearly with this
est and with quality of life score. No signiﬁcant improve-
ent was seen in ventilatory and haemodynamic variables
rom CPX in this population, which appears to be more
ensitive to the response evaluation after CRT than NYHA
tatus.
Concerning technical considerations, pre-ventilatory
hreshold VE/VCO2 slope, peak VE/VCO2 slope and punctual
E/VCO2 ratio were conﬁrmed to be prognostically signiﬁ-
ant, with high reproducibility, in a previous study by Arena
t al. [22]. In our investigation, ventilatory efﬁciency was
easured by the slope of the regression line relating VE
o VCO2 from the beginning to peak exercise, because the
entilatory threshold was not reached for all patients. The
act that this ventilatory expired gas abnormality occurs
arly and does not normalize at any point during exerciseJ. Jaussaud et al.
ay be a primary reason why the pre-ventilatory threshold
E/VCO2 slope, the peak VE/VCO2 slope and the punctual
E/VCO2 ratio are signiﬁcant predictors of outcome and
robably better than peak VO2 in sub-maximal effort and
ymptom-limited exercise [18,20].
The limitations to our study were the small cohort and
etrospective characteristics. In addition, our strict deﬁ-
ition of CRT responders was those with an improvement
f more than 15% in end-systolic volume, as described in
revious studies [5,23], whereas, after implantation, all
atients were in an NYHA symptom class lower than III,
nd all could therefore be considered to be functional
esponders. Hence, certain patients with subjective func-
ional improvement were included in the non-responder
ubgroup. In agreement with the RETHINQ trial, we
onﬁrmed strongly that improvement in NYHA status is
ot necessarily correlated with improvement in ventila-
ory response, peak VO2 and remodelling variables. In
ddition, the evaluation of response to CRT using only
wo-dimensional remodelling variables is debatable. A mul-
ivariable evaluation that includes both rest data (LVEF, left
entricular end-systolic and end-diastolic volumes, systolic
eak strain and strain rate) and effort echocardiographic
ariables is probably needed to deﬁne responders to CRT
orrectly.
onclusion
e ﬁrst conclude that CRT signiﬁcantly increases ventila-
ory and haemodynamic responses at 6 months, independent
f left ventricular remodelling variables. VE/VCO2 slope
nhancement has a prognostic capability that is at least
imilar to peak VO2 and conveys independent predictive
nformation. Our results highlight the potential interest of
ew functional variables such as ventilatory response and
eak CP as better markers for identifying responders to
RT. We suggest that these should be routine components
f analysis of the cardiopulmonary exercise test in chronic
eart failure after CRT. Further studies are needed to doc-
ment the correlation between the evolution in functional
nd morphological variables after CRT, but it is hoped that
his investigation will encourage other groups to perform
imilar investigations leading to the standardization of the
E/VCO2 slope and peak CP, and wider clinical application
f these measures.
onﬂict of interest
one.
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